Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between fluvoxamine and cotinine or caffeine.

Reiji Yoshimura1, Nobuhisa Ueda, Jun Nakamura

  • 1Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan. yoshi621@med.uoeh-u.ac.jp

Neuropsychobiology
|January 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study.

BMC cardiovascular disorders·2021
Same author

Localized gastric amyloidosis diagnosed by endoscopic ultrasound-guided fine-needle aspiration.

Clinical journal of gastroenterology·2021
Same author

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.

JAMA psychiatry·2021
Same author

Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study.

Journal of gastroenterology·2021
Same author

A Pilot Randomized Crossover Trial of Wet Suction and Conventional Techniques of Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Upper Gastrointestinal Subepithelial Lesions.

Gastroenterology research and practice·2021
Same author

Ca<sup>2+</sup>-ATPase Molecules as a Calcium-Sensitive Membrane-Endoskeleton of Sarcoplasmic Reticulum.

International journal of molecular sciences·2021
Same journal

Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.

Neuropsychobiology·2026
Same journal

Decreased Specific Pavlovian-to-Instrumental Transfer Effect in Internet Gaming Disorder Following Short-Term Abstinence from Gaming.

Neuropsychobiology·2026
Same journal

Clinicians' Preferences and Attitudes Toward the Use of Lithium in the Treatment of Bipolar Disorders in Mexico.

Neuropsychobiology·2026
Same journal

Prevalence of psychotic symptoms and their clinical correlates in elderly major depressive disorder patients with subclinical hypothyroidism.

Neuropsychobiology·2026
Same journal

The Long- Term Course of Adolescent-Onset Major Depressive Disorder in Females: A 10-Year Cohort Study on Recurrence, Suicide Risk, and Service Use.

Neuropsychobiology·2026
Same journal

Evidence on Deliberate Self-Harm, Suicidal Ideation and Suicides in Pakistan: A Scoping Review of Methods, Contributing Factors and Associated Mental Disorders.

Neuropsychobiology·2026
See all related articles

Fluvoxamine levels were higher in nonsmokers and correlated positively with caffeine but not cotinine. This suggests cytochrome P450 1A2 is key in fluvoxamine metabolism.

Area of Science:

  • Pharmacology
  • Clinical Psychiatry
  • Drug Metabolism

Background:

  • Major depressive disorder is a common psychiatric condition.
  • Fluvoxamine is a selective serotonin reuptake inhibitor used to treat depression.
  • Individual variability in fluvoxamine pharmacokinetics necessitates understanding its metabolic pathways.

Purpose of the Study:

  • To investigate the relationship between plasma fluvoxamine concentrations and plasma cotinine and caffeine levels.
  • To explore the influence of smoking status on fluvoxamine plasma concentrations.
  • To confirm the role of cytochrome P450 1A2 in fluvoxamine metabolism.

Main Methods:

  • Study included 30 patients diagnosed with major depressive disorder receiving fluvoxamine treatment.
  • Plasma concentrations of fluvoxamine, cotinine, and caffeine were measured under steady-state conditions.

Related Experiment Videos

  • Patients were categorized as smokers (n=11) or nonsmokers (n=19).

    • Main Results:

    • Plasma fluvoxamine concentrations were significantly higher in nonsmokers compared to smokers.
    • A trend towards negative correlation was observed between fluvoxamine and cotinine levels, though not statistically significant.
    • Significant positive correlations were found between plasma fluvoxamine and caffeine concentrations.

    Conclusions:

    • Smoking status significantly impacts plasma fluvoxamine concentrations.
    • The positive correlation with caffeine and trend with cotinine support the role of cytochrome P450 1A2 in fluvoxamine metabolism.
    • These findings enhance understanding of fluvoxamine pharmacokinetics and drug interactions.